Michael Fischbein
Academic Appointments
- Assistant Professor - Med Center Line, Cardiothoracic Surgery - Adult Cardiac Surgery
Key Documents
Contact Information
-
Clinical Offices
Cardiothoracic Surgery Clinic 300 Pasteur Dr Falk CVRB ULN MC:5407 Stanford, CA 94305 Tel Work (650) 724-0831 Fax (650) 723-6954
- Academic Offices
Personal Information EmailNot for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cardiothoracic Surgery
- Aortic Diseases
- Thoracic Surgery
Honors and Awards
- Donald Morton Research Award, Department of Surgery - UCLA School of Medicine (2003)
- Ronald K. Tompkins Golden Apple Teaching Award, UCLA School of Medicine (2003)
- Golden Scalpel Award for Teaching Excellence, Division of General Surgery - UCLA School of Medicine (2003)
- Caves Scientific Award, International Society for Heart and Lung Transplantation - Osaka, Japan (2000)
- Cum Laude Graduate, Boston University School of Medicine (1995)
Professional Education
| Board Certification: | Thoracic Surgery, American Board of Thoracic Surgery (2007) |
| Fellowship: | Stanford University Medical Center CA (2006) |
| Board Certification: | General Surgery, American Board of Surgery (2004) |
| Residency: | UCLA School of Medicine CA (2003) |
| Medical Education: | Boston University Medical Center MA (1995) |
Postdoctoral Advisees
Graduate & Fellowship Program Affiliations
Scientific Focus
Current Research Interests
Mechanisms of allograft rejection, ischemic/reperfusion injury, and molecular and genetic mechanisms of aortic aneurysm/dissection development. Clinical research interests include thoracic aortic diseases (aneurysms, dissections).
Clinical Trials
Publications
- miR-29b Participates in Early Aneurysm Development in Marfan Syndrome. Circ Res. 2012; (2): 312-24
- In vivo functional and transcriptional profiling of bone marrow stem cells after transplantation into ischemic myocardium. Arterioscler Thromb Vasc Biol. 2012; (1): 92-102
- Molecular imaging of bone marrow mononuclear cell survival and homing in murine peripheral artery disease. JACC Cardiovasc Imaging. 2012; (1): 46-55
- A novel cardioprotective agent in cardiac transplantation: metformin activation of AMP-activated protein kinase decreases acute ischemia-reperfusion injury and chronic rejection. Yale J Biol Med. 2011; (4): 423-32
- Interleukin-16 deficiency suppresses the development of chronic rejection in murine cardiac transplantation model. J Heart Lung Transplant. 2011; (12): 1409-17
